title: Which is the optimal testing method for identifying an AV delay that allows intrinsic conduction?
abstract: It is desirable to maintain normal, conducted ventricular activation in patients with dual-chamber pacemakers and preserved atrioventricular (AV) conduction. The shortest AV delay resulting in consistent ventricular inhibition (avoiding ventricular pseudofusion) was determined by a conventional incremental (inside-out) technique vs the alternate decremental (outside-in) technique in 20 such patients. Determinations were made in VDD mode in 20 patients and DDD mode (approximately 10 beats/min faster than the intrinsic rate) in 19. In VDD mode, the shortest AV delay avoiding ventricular pseudofusion was never found during inside-out testing. It was identical with both methods in 10 patients (50%), and shorter by 10-80 ms (mean 20 +/- 20 ms) with the outside-in method in the remaining 10 (P = 0.004). In DDD mode, the shortest AV delay resulting in consistent ventricular inhibition was found only once during inside-out testing. It was the same with both methods in 13 patients (68%), and shorter by 10-20 ms (mean 14 +/- 5 ms) with the outside-in method in the remaining 5 (26%, P = 0.18; Fisher's exact test). The shortest sensed AV delay preventing ventricular pseudofusion is most likely to be found with a decremental method (outside-in). In rare patients, it identifies AV delays resulting in inhibition, while ventricular pacing persists at longer programmable AV delays with the conventional inside-out approach.
authors.affiliation: Section of Cardiology, Rush-Presbyterian-St. Luke's Medical Center and Rush Medical College, Chicago, Illinois, USA.
authors.forename: L E
authors.initials: LE
authors.lastname: Eguía
authors.forename: S L
authors.initials: SL
authors.lastname: Pinski
authors.forename: J
authors.initials: J
authors.lastname: Haw
authors.forename: R G
authors.initials: RG
authors.lastname: Trohman
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016275:Atrial Function; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D017147:Defibrillators, Implantable; D005260:Female; D006329:Heart Conduction System / Q000503:physiopathology*; D006331:Heart Diseases / Q000503:physiopathology* / Q000628:therapy; D006339:Heart Rate; D006801:Humans; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial; D011930:Reaction Time; D016276:Ventricular Function